Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
37 studies found for:    Open Studies | "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
1 Recruiting Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Intervention:
2 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
3 Recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
4 Recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
5 Recruiting Oxidation Rates of the Different Substrates During Exercise in Children and Adolescents With Juvenile Idiopathic Arthritis. Case-control Study and Cases Treated / Cases Not Treated With Anti-TNFα
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: anti-TNFα
6 Recruiting An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
7 Recruiting The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Behavioral: iPeer2Peer Mentorship;   Other: Active Comparator: Control Group
8 Not yet recruiting Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)
Condition: Juvenile Idiopathic Arthritis
Interventions: Dietary Supplement: VSL#3;   Other: Placebo
9 Recruiting Long-Term Safety Study Of Tofacinib In Patients With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tofacitinib
10 Recruiting Biomarkers in Idiopathic Juvenile Arthritis
Condition: Idiopathic Juvenile Arthritis
Intervention: Other: blood sample for identifying biomarkers
11 Recruiting A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
12 Recruiting A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (sJIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Sarilumab SAR153191 (REGN88)
13 Recruiting Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
14 Recruiting A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Tocilizumab
15 Recruiting An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Sarilumab SAR153191 (REGN88)
16 Recruiting Study of Methotrexate Given to Juvenile Idiopathic Arthritis Patients Based on Pharmacogenomics and Pharmacometrics
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: therapeutic drug monitoring
17 Recruiting Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis;   Temporomandibular Arthritis
Intervention:
18 Recruiting A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
Conditions: Systemic Juvenile Idiopathic Arthritis;   Hereditary Periodic Fevers
Intervention: Drug: canakinumab
19 Not yet recruiting Treatment Tapering in JIA With Inactive Disease
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: etanercept;   Drug: adalimumab;   Drug: Abatacept;   Drug: Tocilizumab
20 Recruiting Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Condition: Juvenile Idiopathic Arthritis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.